Real‐world results with <scp>IgPro20</scp> for hypo‐ or agammaglobulinemia in Japan-Reference-Cited by-同舟云学术

Real‐world results with IgPro20 for hypo‐ or agammaglobulinemia in Japan

Published:2022-01 Issue:1 Volume:64 Page:
ISSN:1328-8067
Container-title:Pediatrics International
language:en
Short-container-title:Pediatrics International

Author:

Imai Kohsuke¹^ORCID,Ishii Tomonori²,Nonoyama Shigeaki³,Yasumi Takahiro⁴,Kanegane Hirokazu⁵^ORCID,Fukushima Taku⁶,Matsumaru Masayuki⁶,Akasaki Tetsushi⁷,Usui Hideo⁷

Affiliation:

1. Department of Community Pediatrics, Perinatal and Maternal Medicine Tokyo Medical and Dental University (TMDU) Tokyo Japan

2. Clinical Research, Innovation and Education Center Tohoku University Hospital Miyagi Japan

3. Department of Pediatrics National Defense Medical College Saitama Japan

4. Department of Pediatrics Kyoto University Graduate School of Medicine Kyoto Japan

5. Department of Child Health and Development Tokyo Medical and Dental University (TMDU) Tokyo Japan

6. Medical Affairs CSL Behring K.K. Tokyo Japan

7. Department of Pharmacovigilance CSL Behring K.K. Tokyo Japan

Publisher

Wiley

Subject

Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ped.15362

Reference31 articles.

1. Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee

2. International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity

3. Practice parameter for the diagnosis and management of primary immunodeficiency

4. The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management

5. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-globulin;Reactions Weekly;2023-01-21

2. Management of secondary immunodeficiency in hematological malignancies in the era of modern oncology;Critical Reviews in Oncology/Hematology;2023-01